Aptar Pharma launches APF Futurity metal-free nasal spray pump for OTC products

Aptar Pharma announced that it has launched a metal-free multidose nasal spray pump called APF Futurity for delivery of over-the-counter formulations. According to Aptar Pharma, APF Futurity is designed to be recyclable without removing the pump from a container bottle and has received Class AA certification from cyclos-HT.

Aptar Product Sustainability Director Christophe Marie said, “Aptar continues to receive recognition for our sustainable product innovations, including the Institute of Packaging Professionals (IOPP) and WorldStar Global Packaging awards, and we were recently ranked #15 on Newsweek’s ‘America’s Most Responsible Companies‘ list. Aptar Pharma’s launch of APF Futurity is yet another sustainable product innovation that reinforces our pledge to care for our planet and reduce our environmental impact.”

The company’s President, Global Market Development, Consumer Health Care, Stefan Ritsche added, “APF Futurity is a game-changing innovation for the nasal spray pump industry and I am proud of our design and engineering team for meeting the challenge of designing this metal-free nasal pump. This is an important step in the transformation of our nasal spray portfolio to more sustainable solutions, and we look forward to bringing additional innovations of this kind to meet the need in the pharmaceutical industry.”

Aptar Pharma President Gael Touya said, “As a leading provider of nasal spray pumps globally, the launch of APF Futurity is a significant step forward in our sustainability journey, underlining Aptar’s overall commitment to a more circular economy and meeting the global need for sustainable packaging solutions that are easy to recycle.”

Read the Aptar Pharma press release.

Share

published on

Featured event:

July 13-July 162026 ISAM Congress, Taipei, Taiwan

September 15-September 18DDL New Researcher Network Summer Event, London, UK

September 16-September 17IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA

September 24-September 25Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK